233,794 CVS Health Corporation $CVS Shares Acquired by Hamlin Capital Management LLC

Hamlin Capital Management LLC grew its stake in shares of CVS Health Corporation (NYSE:CVS) by 13.6% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,951,402 shares of the pharmacy operator’s stock after acquiring an additional 233,794 shares during the period. CVS Health accounts for 4.1% of Hamlin Capital Management LLC’s holdings, making the stock its 12th largest position. Hamlin Capital Management LLC owned about 0.15% of CVS Health worth $167,216,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Elevation Wealth Partners LLC increased its stake in CVS Health by 41.8% during the second quarter. Elevation Wealth Partners LLC now owns 356 shares of the pharmacy operator’s stock valued at $37,000 after purchasing an additional 105 shares during the last quarter. Apella Capital LLC grew its position in shares of CVS Health by 1.7% during the 2nd quarter. Apella Capital LLC now owns 6,940 shares of the pharmacy operator’s stock valued at $724,000 after buying an additional 117 shares during the last quarter. Wellington Altus USA Inc. raised its stake in CVS Health by 13.3% during the second quarter. Wellington Altus USA Inc. now owns 1,025 shares of the pharmacy operator’s stock worth $106,000 after acquiring an additional 120 shares during the period. CoreCap Advisors LLC grew its holdings in shares of CVS Health by 4.2% during the second quarter. CoreCap Advisors LLC now owns 3,481 shares of the pharmacy operator’s stock valued at $360,000 after purchasing an additional 139 shares during the last quarter. Finally, AGP Franklin LLC lifted its holdings in shares of CVS Health by 1.3% in the 1st quarter. AGP Franklin LLC now owns 11,563 shares of the pharmacy operator’s stock worth $830,000 after purchasing an additional 146 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Key CVS Health News

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: CVS extended pharmaceutical distribution agreements with Cardinal Health and McKesson through 2032. The agreements secure a long-term supply-chain foundation for its retail pharmacies and other dispensing channels, reducing distribution uncertainty. What Does CVS Health Gain From Extending Its Drug Distribution Deals?
• Positive Sentiment: CVS raised its Health Care Benefits outlook as stronger Medicare trends support potential margin recovery, although higher medical costs remain a constraint. This is an important earnings-positive development for Aetna, CVS’s insurance segment. CVS Health Care Benefits Arm Shows Better Core Trends
• Positive Sentiment: Aetna’s 2027 Medicare Advantage plans will be offered in 41 states plus Washington, D.C., with expanded chronic-condition plans and provider-incentive programs. Broader access and care-navigation efforts could support membership and retention. Aetna 2027 Medicare Plans
• Positive Sentiment: CVS opened its first pharmacy-focused location in the Boston area, emphasizing medication access, immunizations and pharmacist-led services. The compact format may help CVS serve targeted markets with a more focused retail footprint. CVS Opens Pharmacy-Focused Boston Location
• Neutral Sentiment: Analysts and financial commentators continue to describe CVS as attractively valued or a potential growth stock, but these views are based largely on valuation models and style rankings rather than new operating results. Why CVS Health Is a Strong Growth Stock
• Negative Sentiment: Investors remain concerned that CVS’s integrated-care strategy could require substantial execution and investment before producing stronger returns. Those concerns may keep the shares below estimated fair value despite their relatively modest valuation. CVS Stock May Trade Below Fair Value

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on the company. HSBC reiterated a “hold” rating and issued a $103.00 target price on shares of CVS Health in a research note on Monday, July 6th. Barclays boosted their price objective on CVS Health from $106.00 to $108.00 and gave the stock an “overweight” rating in a research report on Thursday, August 6th. Wall Street Zen lowered CVS Health from a “strong-buy” rating to a “buy” rating in a research report on Saturday, October 3rd. UBS Group reaffirmed a “buy” rating on shares of CVS Health in a report on Tuesday, September 22nd. Finally, Robert W. Baird set a $107.00 price objective on shares of CVS Health in a report on Thursday, August 6th. Twenty-two analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $107.24.

CVS Health Price Performance

Shares of NYSE CVS traded up $0.32 during midday trading on Thursday, reaching $88.27. The company’s stock had a trading volume of 2,734,529 shares, compared to its average volume of 8,276,981. CVS Health Corporation has a one year low of $69.51 and a one year high of $110.68. The company has a market cap of $112.89 billion, a price-to-earnings ratio of 23.32, a price-to-earnings-growth ratio of 0.84 and a beta of 0.60. The company has a 50 day moving average price of $93.45 and a 200 day moving average price of $92.30. The company has a current ratio of 0.87, a quick ratio of 0.66 and a debt-to-equity ratio of 0.74.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.87 by $0.71. The firm had revenue of $106.10 billion for the quarter, compared to analyst estimates of $100.03 billion. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The firm’s quarterly revenue was up 7.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.81 earnings per share. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. On average, equities research analysts expect that CVS Health Corporation will post 8.02 EPS for the current year.

CVS Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, November 2nd. Stockholders of record on Thursday, October 22nd will be issued a dividend of $0.6650 per share. This represents a $2.66 annualized dividend and a dividend yield of 3.0%. The ex-dividend date of this dividend is Thursday, October 22nd. CVS Health’s dividend payout ratio is currently 70.37%.

CVS Health Profile

CVS Health Corp. is an integrated health care company that provides pharmacy, insurance and health services primarily in the United States. Its operations are designed to connect consumers, health plans, health care providers and pharmacy services across multiple points of care.

The company’s major businesses include CVS Pharmacy retail locations, prescription fulfillment and consumer health products; CVS Caremark, a pharmacy benefit management business; and Aetna, which offers health insurance products and related services for employers, individuals, government programs and other organizations.